CNBT
WST icon

Canandaigua National Bank & Trust’s West Pharmaceutical WST Stock Holding History

Canandaigua National Bank & Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-778
Closed -$234K – 347
2024
Q3 		$234K Sell
778
-126
-14% -$38.6K 0.02% 308
2024
Q2 		$298K Sell
904
-3
-0.3% -$1.06K 0.03% 250
2024
Q1 		$359K Sell
907
-11
-1% -$4.07K 0.05% 199
2023
Q4 		$323K Sell
918
-4
-0.4% -$1.42K 0.05% 203
2023
Q3 		$346K Sell
922
-16
-2% -$6.19K 0.06% 185
2023
Q2 		$359K Sell
938
-16
-2% -$5.72K 0.06% 191
2023
Q1 		$331K Buy
+954
New +$279K 0.06% 197

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Canandaigua National Bank & Trust's WST Position: Q4 2024 in Review

Canandaigua National Bank & Trust sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 778 shares — an estimated $234K sold.

Canandaigua National Bank & Trust first reported a position in WST in Q1 2023 and held it in 7 quarters. The position peaked at $359K in Q1 2024. 747 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Canandaigua National Bank & Trust reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Canandaigua National Bank & Trust sold 778 West Pharmaceutical shares in Q4 2024, an estimated $234K.
  • Canandaigua National Bank & Trust first reported a position in West Pharmaceutical in Q1 2023 and held it in 7 quarters.
  • Canandaigua National Bank & Trust's West Pharmaceutical position peaked at $359K in Q1 2024.
  • 747 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Canandaigua National Bank & Trust's 13F filing for Q4 2024, filed 6 Jan 2025.